Aromatase inhibitors, like Arimidex, block the enzyme aromatase. This enzyme converts androgens (male hormones) into estrogens (female hormones).
Breast cancer cells often rely on estrogen for growth. By inhibiting aromatase, Arimidex reduces estrogen levels, slowing or stopping tumor growth. This is particularly effective in hormone receptor-positive breast cancers.
Postmenopausal women are common candidates for aromatase inhibitor therapy. Their bodies produce less estrogen naturally, making aromatase inhibition a more targeted approach.
Potential side effects include joint pain, hot flashes, and bone thinning. Your doctor will discuss these risks and monitor your health closely during treatment.
Aromatase inhibitors are frequently used as First-line therapy after surgery or in combination with other treatments, such as chemotherapy or radiotherapy. The specific treatment plan depends on the individual’s cancer stage and overall health.
Regular blood tests monitor the effectiveness of the treatment and detect any potential complications. Open communication with your oncologist is key to managing the therapy and addressing any concerns.
Remember: This information provides a general overview. Consult your healthcare professional for personalized advice tailored to your specific situation. They will help determine if Arimidex is the right treatment for you.
